CD55 anticorps (AA 51-150)

N° du produit ABIN7090997

Cet anticorps anti-CD55 est un anticorps Souris Monoclonal détectant CD55 dans WB. Adapté pour Humain.

Aperçu rapide pour CD55 anticorps (AA 51-150) (ABIN7090997)

Antigène: CD55 (Complement Decay-Accelerating Factor (CD55))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CD55 est non-conjugé

Application: Western Blotting (WB)

Clone: D5FF2

Détail du produit anti-CD55 anticorps

Épitope: AA 51-150

Homologie: Human

Immunogène: KLH conjugated synthetic peptide derived from human CD55

Isotype: IgG1

Information d'application

Indications d'application: WB 1:300-5000

Restrictions: For Research Use only

Stockage

Concentration: 0.5 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Date de péremption: 12 months

Détails sur CD55

Antigène: CD55 (Complement Decay-Accelerating Factor (CD55))

Autre désignation: CD55

Sujet:

Synonyms: CD 55, CD55 antigen, CD55 Cromer blood group system, CD55 Molecule, CD55 Molecule, decay accelerating factor for complement (Cromer blood group), Cd55a, Complement decay accelerating factor, Complement decay-accelerating factor, Complement decay-accelerating factor, GPI-anchored, CR, CROM, Cromer Blood Group antigen, Cromer blood group system, DAF, Daf-GPI, DAF_HUMAN, Daf1, Dcay accelerating factor for complement (CD55, Cromer blood group system), Decay accelarating factor 1, isoform CRA_a, Decay accelerating factor (GPI-form), Decay Accelerating Factor for Complement, Decay accelerating factor GPI-form, Decay accelerating factor soluble-form, GPI-DAF, TC.

Background: This protein recognizes C4b and C3b fragments that condense with cell-surface hydroxyl or amino groups when nascent C4b and C3b are locally generated during C4 and c3 activation. Interaction of daf with cell-associated C4b and C3b polypeptides interferes with their ability to catalyze the conversion of C2 and factor B to enzymatically active C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the amplification convertases of the complement cascade.

ID gène: 1604

UniProt: P08174

Pathways: Système du Complément, Regulation of Leukocyte Mediated Immunity